Clinical Trial Update: Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival [Phase 1, Phase 2]

View source ↗

Summary

Bevacizumab was studied for safety and efficacy in high-risk corneal transplantation. The trial focused on corneal neovascularization and graft survival, with P…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Graft Failure
• Corneal Neovascularization

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Reza Dana, MD | Conditions: Corneal Neovascularization, Corneal Graft Failure | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-05-15